Table:
begin	end	state
1	27	cytoplasmic
28	50	transmembrane
51	62	non-cytoplasmic
63	82	transmembrane
83	92	cytoplasmic
93	112	transmembrane
113	118	non-cytoplasmic
119	140	transmembrane
141	150	cytoplasmic
151	172	transmembrane
173	177	non-cytoplasmic
178	202	transmembrane
203	250	cytoplasmic
251	280	transmembrane
281	298	non-cytoplasmic
299	319	transmembrane
320	327	cytoplasmic
328	344	transmembrane
345	349	non-cytoplasmic
350	368	transmembrane
369	387	cytoplasmic
388	412	transmembrane
413	418	non-cytoplasmic
419	440	transmembrane
441	446	cytoplasmic

Input:
>GFF1317 FitnessBrowser__WCS417:GFF1317
MNQPSVGTPLDVQSFINAQPLSRYQWRVVILCFLIVFLDGLDTAAMGFIAPALSQDWGID
RASLGPVMSAALIGMVFGALGSGPLADRFGRKVVLVGAVLVFGAFSLASAYSSNVDQLLV
LRFLTGLGLGAGMPNATTLLSEYTPERHKSLLVTSMFCGFNLGMAGGGFISAKLIPAFGW
HALLLIGGILPLILVVVLMLWLPESARYLVVRNRGTDKVRKTLSPIDPVIVGQATSFSVP
EQKTVKARNVFAVIFSGTYSAGTLLLWLTYFMGLVIVYLLTSWLPTLMRDSGASLEQAAF
IGALFQFGGVLSAVGVGWAMDRFNPHKVIGSFYLLAGVFAYAVGQSLGNITLLATLVLIA
GMCVNGAQSAMPSLAARFYPTQGRATGVSWMLGIGRFGAILGAWMGATLLGLGWNFEQVL
TALVIPAALATAAVVIKGMVSHADAT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server